Innovative AAV Production Service for Targeted Gene Delivery

Safely and efficiently deliver target genes into your cells

AMSBIO is a leading provider of ready-to-use Adeno-Associated Virus (AAV) that can be engineered to efficiently deliver specific DNA sequences into target cells with a low immunogenicity.

Leveraging years of expertise and pioneering research, AMSBIO has developed a robust AAV Production Service, offering scientists access to the highest quality recombinant AAV vectors that can effectively transfect various cell types, including both dividing and non-dividing cells. These AAV vectors induce sustained gene expression in vivo, without integrating into the host genome or causing any adverse effects, making them an ideal platform for gene delivery in the treatment of diverse human diseases, including cancer. Already, AAV-mediated gene replacement, gene silencing, and gene editing have achieved promising preclinical and clinical outcomes.

As a recognised authority in AAV technology, AMSBIO's custom production service is specifically designed to assist researchers in designing, cloning, and viral packaging of their unique AAV constructs. The service encompasses a wide range of AAV serotypes (1-9, DJ), each displaying distinct tropism, enabling preferential transduction of specific cell types.

Starting from the provided target templates, cDNA collections, custom synthesised DNA sequences, or shRNA, AMSBIO meticulously constructs the AAV clone and delivers ready-to-use expression AAV. Through their production service, AMSBIO precisely sub-clones selected genes into their AAV expression vectors, ultimately generating expression AAV for each individual gene.

By utilising AMSBIO's AAV production service, researchers can rely on consistent, reproducible, high-purity viral stocks with every order. The service guarantees high titre viral stocks, ensuring the utmost quality and reliability for experimental needs.

More information online